When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
LLY - Sermonix teams up with Lilly in study of doublet therapy in type of breast cancer
Eli Lilly and Company
Eli Lilly (LLY+1.3%) will collaborate with privately held Sermonix in an open-label Phase 2 clinical trial, ELAINE 2, evaluating the combination of Verzenio (abemaciclib) and the latter's lead drug lasofoxifene in pre- and postmenopausal women with locally advanced/metastatic ER+/HER2- breast cancer and an ESR1 mutation. Enrollment should launch this quarter.
More news on: Eli Lilly and Company, Ligand Pharmaceuticals Incorporated, Healthcare stocks news,